Sino Biopharmaceutical Limited: Pulmonary Disease, Chronic Obstructive trials
The registry lists 17 Pulmonary Disease, Chronic Obstructive studies with Sino Biopharmaceutical Limited as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 1 7Phase 2 8Phase 3 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Evaluation of the Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseRecruitingNCT07464587Phase 3
- Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseNot yet recruitingNCT07147946Phase 3
- A Clinical Trial Comparing TQC3927 Inhaled Powder With Glycopyrronium Bromide and Formoterol Inhaled Aerosol (Biovoping® Lingchang®) for the Treatment of Chronic Obstructive Pulmonary DiseaseSuspendedNCT07633314Phase 2
- A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult SubjectsTerminatedNCT07267130Phase 1
- A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation PowderCompletedNCT07252908Phase 2
- A Clinical Study to Evaluate the Efficacy and Safety of TQC2938 in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseActive, not recruitingNCT06789289Phase 2
- A Clinical Study of TQC3721 Inhalation Powder in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT06748079Phase 1
- A Clinical Trial of TQC3927 Powder for Inhalation in Chronic Obstructive Pulmonary DiseaseCompletedNCT06711991Phase 1
- A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseActive, not recruitingNCT06707883Phase 2
- A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT06527144Phase 2
- A Trial to Assess the Bioequivalence of Tiotropium Bromide Inhalation Powder in Healthy Adult Participants Under Fasting ConditionsActive, not recruitingNCT06487416Phase 1
- A Study of TQC3927 Powder for Inhalation in Healthy Adult SubjectsCompletedNCT06408285Phase 1
- A Trial to Assess the Bioequivalence of Generic Tiotropium Bromide Inhalation Powder and Reference Product in Healthy Adult Participants Under Fasting Conditions (Pilot)Active, not recruitingNCT06326671Phase 1
- A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease.CompletedNCT05987371Phase 2
- A Phase II Clinical Trial of TQC3721 Suspension for InhalationTerminatedNCT05292196Phase 2
- A Clinical Trial of TQC3721 Suspension for InhalationStatus unknownNCT05051930Phase 1
- A Multicenter Randomized Double-blind Clinical Study Evaluated the Safety, Pharmacokinetic and Pharmacodynamic Characteristics of Roflumilast in COPD PatientsTerminatedNCT02671942Phase 2